|
Explains why anti-angiogenic therapy is effective for various ocular diseases
Highlights the advantages and limitations of anti-angiogenic therapy
Written by established experts in their respective fields
This book provides a concise overview over the pathology of retinal angiogenic diseases and explains why anti-angiogenic therapy is effective in so many patients. The reader is
guided through the various clinical indications for anti-angiogenic therapy and made aware of its merits as well as current challenges and limitations. It is explained how, since its introduction for the treatment of exudative age-related macular degeneration in 2006, anti-angiogenic therapy has revolutionized the way in which we treat a range of ocular diseases.
All of the authors are established experts in their respective fields who share their extensive knowledge and clinical experience with the reader. This book is both a valuable introduction to anti-angiogenic therapy in ophthalmology and a day-to-day companion for all ophthalmologists seeing patients with some of the most prevalent retinal diseases.
Table of Contents
- 1 Retinal Vascular Development
Jing Chen, Chi-Hsiu Liu, and Przemyslaw Sapieha
2 Retinopathy of Prematurity
Andreas Stahl, Ann Hellstrom, and Lois E. H. Smith
- 3 Anti-Vascular Endothelial Growth Factor (VEGF) Treatment in Neovascular Age-Related Macular Degeneration: Outcomes and Outcome Predictors
Dujon Fuzzard, Robyn H. Guymer, and Robert P. Finger
- 4 AREDS Supplementation and the Progression Towards Neovascular Exudative AMD
David Valent and Emily Y. Chew
- 5 VEGF-Inhibition in Macular Telangiectasia Type 2
Peter Charbel Issa and Frank G. Holz
- 6 Diabetic Retinopathy
Focke Ziemssen and Hansjürgen T. Agostini
- 7 Retinal Vein Occlusion
Amelie Pielen, Bernd Junker, and Nicolas Feltgen
- 8 Pharmacokinetics of Intravitreally Applied VEGF Inhibitors
Tim U. Krohne, Frank G. Holz, and Carsten H. Meyer
- 9 Neovascular Glaucoma
Julia Lüke, Matthias Lüke, and Salvatore Grisanti
- 10 Corneal Neovascular Diseases
Deniz Hos, Felix Bock, Björn Bachmann, and Claus Cursiefen
- 11 AntiAngiogenic Gene Therapy - Basic Science and Challenges for Translation-into the Clinic
Clemens Lange and James Bainbridge
|
